Alpine Immune Sciences Stock Price Prediction

ALPN Stock  USD 36.00  0.78  2.21%   
the RSI of Alpine Immune's share price is above 70 as of today. This suggests that its stock is becoming overbought or overvalued. The idea behind Relative Strength Index (RSI) is that it helps to track how fast people are buying or selling a stock, making its price go up or down.

Oversold Vs Overbought

74

 
Oversold
 
Overbought
Alpine Immune Sciences stock price prediction is an act of determining the future value of Alpine Immune shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Alpine Immune's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Alpine Immune and does not consider all of the tangible or intangible factors available from Alpine Immune's fundamental data. We analyze noise-free headlines and recent hype associated with Alpine Immune Sciences, which may create opportunities for some arbitrage if properly timed.
Below are the key fundamental drivers impacting Alpine Immune's stock price prediction:
EPS Estimate Next Quarter
(0.29)
EPS Estimate Current Year
(1.10)
EPS Estimate Next Year
(1.49)
Wall Street Target Price
33.57
EPS Estimate Current Quarter
(0.33)
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Alpine Immune based on different types of headlines from major news networks to social media. The Alpine stock price prediction module provides an analysis of price elasticity to changes in media outlook on Alpine Immune over a specific investment horizon. Using Alpine Immune hype-based prediction, you can estimate the value of Alpine Immune Sciences from the perspective of Alpine Immune response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Alpine Immune using Alpine Immune's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Alpine using crowd psychology based on the activity and movement of Alpine Immune's stock price.

Alpine Immune Implied Volatility

    
  123.64  
Alpine Immune's implied volatility exposes the market's sentiment of Alpine Immune Sciences stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Alpine Immune's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Alpine Immune stock will not fluctuate a lot when Alpine Immune's options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in Alpine Immune. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Alpine Immune to buy its stock at a price that has no basis in reality. In that case, they are not buying Alpine because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Alpine Immune after-hype prediction price

    
  USD 36.13  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Alpine Immune Basic Forecasting Models to cross-verify your projections.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Alpine Immune's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Alpine Immune in the context of predictive analytics.
Intrinsic
Valuation
LowRealHigh
23.1227.3639.60
Details
Naive
Forecast
LowNextHigh
33.1037.3341.57
Details
8 Analysts
Consensus
LowTargetHigh
16.6418.2920.30
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.33-0.34-0.24
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Alpine Immune. Your research has to be compared to or analyzed against Alpine Immune's peers to derive any actionable benefits. When done correctly, Alpine Immune's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Alpine Immune Sciences.

Alpine Immune After-Hype Price Prediction Density Analysis

As far as predicting the price of Alpine Immune at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Alpine Immune or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Alpine Immune, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Alpine Immune Estimiated After-Hype Price Volatility

In the context of predicting Alpine Immune's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Alpine Immune's historical news coverage. Alpine Immune's after-hype downside and upside margins for the prediction period are 31.89 and 40.37, respectively. We have considered Alpine Immune's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
36.00
36.13
After-hype Price
40.37
Upside
Alpine Immune is not too volatile at this time. Analysis and calculation of next after-hype price of Alpine Immune Sciences is based on 3 months time horizon.

Alpine Immune Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Alpine Immune is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Alpine Immune backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Alpine Immune, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  1.49 
4.24
  0.13 
  0.16 
8 Events / Month
7 Events / Month
In about 8 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
36.00
36.13
0.36 
4,711  
Notes

Alpine Immune Hype Timeline

Alpine Immune Sciences is presently traded for 36.00. The entity has historical hype elasticity of 0.13 and average elasticity to hype of competition of -0.16. Alpine is projected to increase in value after the next headline with the price projected to jump to 36.13 or above. The average volatility of media hype impact on the company stock price is over 100%. The price boost on the next news is projected to be 0.36% whereas the daily expected return is presently at 1.49%. The volatility of related hype on Alpine Immune is about 3925.93% with expected price after next announcement by competition of 35.84. The company reported the previous year's revenue of 30.8 M. Net Loss for the year was (57.01 M) with loss before overhead, payroll, taxes, and interest of (40.18 M). Given the investment horizon of 90 days the next projected press release will be in about 8 days.
Check out Alpine Immune Basic Forecasting Models to cross-verify your projections.

Alpine Immune Related Hype Analysis

Having access to credible news sources related to Alpine Immune's direct competition is more important than ever and may enhance your ability to predict Alpine Immune's future price movements. Getting to know how Alpine Immune rivals react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Alpine Immune may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
AAgilent Technologies(0.29)8 per month 1.34  0.01  2.31 (2.26) 9.31 
EQEquillium 0.1 9 per month 4.54  0.26  24.49 (9.59) 70.42 
KAKineta Inc(0.42)6 per month 0.00 (0.15) 8.54 (7.94) 74.29 
ME23Andme Holding Co(0.03)10 per month 0.00 (0.12) 10.47 (9.57) 34.64 
YSYS Biopharma Co 0.00 8 per month 0.00 (0.09) 9.80 (10.20) 31.19 
DMACDiaMedica Therapeutics(0.01)5 per month 3.37  0.04  6.38 (6.72) 20.43 
DMTKDermTech(0.14)10 per month 0.00 (0.11) 9.21 (7.83) 27.44 
VALNValneva SE ADR(0.25)5 per month 0.00 (0.27) 5.47 (4.94) 18.59 
VANIVivani Medical(0.02)11 per month 3.66  0.12  5.68 (4.67) 257.46 
VAXXVaxxinity(0.02)6 per month 0.00 (0.06) 8.45 (9.41) 45.91 

Alpine Immune Additional Predictive Modules

Most predictive techniques to examine Alpine price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Alpine using various technical indicators. When you analyze Alpine charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Alpine Immune Predictive Indicators

The successful prediction of Alpine Immune stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Alpine Immune Sciences, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Alpine Immune based on analysis of Alpine Immune hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Alpine Immune's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Alpine Immune's related companies.
 2010 2019 2023 (projected)
PPandE Turnover0.621.271.14
Long Term Debt to Equity0.05120.150.14

Story Coverage note for Alpine Immune

The number of cover stories for Alpine Immune depends on current market conditions and Alpine Immune's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Alpine Immune is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Alpine Immune's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Alpine Immune Short Properties

Alpine Immune's future price predictability will typically decrease when Alpine Immune's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Alpine Immune Sciences often depends not only on the future outlook of the potential Alpine Immune's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Alpine Immune's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding33.4 M
Cash And Short Term Investments237.6 M
When determining whether Alpine Immune Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Alpine Immune's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Alpine Immune Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Alpine Immune Sciences Stock:
Check out Alpine Immune Basic Forecasting Models to cross-verify your projections.
You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Complementary Tools for Alpine Stock analysis

When running Alpine Immune's price analysis, check to measure Alpine Immune's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alpine Immune is operating at the current time. Most of Alpine Immune's value examination focuses on studying past and present price action to predict the probability of Alpine Immune's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alpine Immune's price. Additionally, you may evaluate how the addition of Alpine Immune to your portfolios can decrease your overall portfolio volatility.
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
CEOs Directory
Screen CEOs from public companies around the world
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Is Alpine Immune's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alpine Immune. If investors know Alpine will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alpine Immune listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.29)
Revenue Per Share
0.67
Quarterly Revenue Growth
0.2
Return On Assets
(0.16)
Return On Equity
(0.33)
The market value of Alpine Immune Sciences is measured differently than its book value, which is the value of Alpine that is recorded on the company's balance sheet. Investors also form their own opinion of Alpine Immune's value that differs from its market value or its book value, called intrinsic value, which is Alpine Immune's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alpine Immune's market value can be influenced by many factors that don't directly affect Alpine Immune's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alpine Immune's value and its price as these two are different measures arrived at by different means. Investors typically determine if Alpine Immune is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alpine Immune's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.